Edition: Australia  
One News Page
“Probably the fastest-access news portal in the world”
> >

Naia Rare Diseases Announces Clinical Trial Authorisation (CTA) to Initiate Clinical Trials of NB 1001 for Short Bowel Syndrome in the United Kingdom

Marketwired Wednesday, 15 November 2017 ()
RICHMOND, CA--(Marketwired - November 15, 2017) - Naia Rare Diseases, a biopharmaceutical company developing drugs for Short Bowel Syndrome (SBS) and other rare gastrointestinal diseases today announced that it has received Clinical Trial Authorisation ("CTA") from the Medicine and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom to initiate a clinical trial of its long-acting GLP-1 agonist, NB 1001, in adult patients with SBS.
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 

Recent related news

Paradigm Biopharmaceuticals meets primary endpoint in clinical trial

Paradigm Biopharmaceuticals (ASX:PAR) has received results from its phase 2a clinical trial in bone marrow lesions (bone bruising) as a result of an anterior...
Proactive Investors - Business

Prima BioMed granted European patent for its lead cancer product

Prima BioMed Limited (ASX:PRR) has been granted a patent geared toward the use of its lead candidate IMP321 in combination with a chemotherapeutic agent for the...
Proactive Investors - Business


You Might Like


Other recent news in Press Releases

Groupon Finds That Most People Plan to Start Their BLACK FRIDAY Shopping at 3:29 p.m. on Thanksgiving!Video: THANKSGIVING Holiday Exclusive! Lions Devour Formal THANKSGIVING Feast at the Columbus Zoo
AstroNova Reports Record REVENUE and Bookings for Third Quarter of Fiscal 2018CALIFORNIA American Water Teams up with State Senator Jim Nielsen for “Operation Gobble”
EQUITY ALERT: Rosen Law Firm Announces FILING of Securities Class Action Lawsuit Against Triangle Capital CorporationThe Cheesecake Factory Opens First Restaurant in CANADA
PMI-Supported Report Language to Maintain WaterSense Program Included in Senate EPA BUDGET BillA.M. BestTV at LONDON Market Briefing: After a Succession of Catastrophes, a Pause Before Impact
Fluor Announces the Arrival of Hundreds of Vehicles and Equipment in PUERTO RICO to Help Support Power RestorationIlan Kenig, CEO of FMB Development, To Light Iconic Venice Sign for HOLIDAYS

Twitter

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+